Table 1.
Demographic and clinical characteristics of participants, overall and for those contributing to each calendar period (n = 22,937).
Table 2.
Population size, deaths, and unweighted mortality rate, overall and by select categories, 2000 to 2007.
Figure 1.
Age-specific unweighted mortality rates (per 1000 person-years), by calendar-period, among individuals on ART in the NA-ACCORD, 2000–2007.
Note: PY, person-years; ART, combination antiretroviral therapy.
Table 3.
Life expectancy estimates (LEE) and standard errors (SE) at age 20 years using weighted and unweighted mortality rates, 2000 to 2007.
Figure 2.
Mid-point life expectancy estimates at age 20 years in three calendar periods, overall and by sociodemographic characteristics, 2000–2007.
Panel A: Life expectancy at age 20 years, overall. Panel B: Life expectancy at age 20 years, by sex. Panel C: Life expectancy at age 20 years, by transmission group. Panel D: Life expectancy at age 20 years, by race. Panel E: Life expectancy at age 20 years, by CD4 cell count (cells/mm3) at ART initiation.
Table 4.
Life expectancy estimates (LEE) and standard errors (SE) at age 20 years using unweighted mortality rates, by calendar period, 2000 to 2007.